Antidepressants for COVID-19: A systematic review
Authors:
- 23 March 2022
- journal article
- review article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 307, 108-114
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysisThe Lancet, 2018
- Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-AnalysisMolecular Neurobiology, 2017
- Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implicationJournal of Pharmacological Sciences, 2015
- Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugsNature Medicine, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-AnalysisNeuropsychopharmacology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Effects of fluoxetine on mast cell morphology and protease-1 expression in gastric antrum in a rat model of depressionWorld Journal of Gastroenterology, 2008
- Purification, molecular cloning, and expression of the mammalian sigma1-binding site.Proceedings of the National Academy of Sciences, 1996
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996